Abirapro 250 mg Tablet 120s
MRP: ₹28,000.00
Packaging
TAB
Composition
Abirateron 250mg
Company
Glenmark
MRP: ₹28,000.00
Packaging
TAB
Composition
Abirateron 250mg
Company
Glenmark
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Abatitor 250mg Tablet 30s | Torrent Pharma | ₹9,900.00 | Save ₹18,100.00 |
| Abatitor 250mg Tablet 60s | Torrent Pharma | ₹19,900.00 | Save ₹8,100.00 |
| Zelgor 250 mg Tablet 120s | Sun Pharma | ₹25,000.00 | Save ₹3,000.00 |
| Celbira 250mg Tablet 120s | Celon Labs | ₹28,000.00 | — |
| Xbira 250 mg Tablet 120s | CIPLA | ₹28,500.00 | — |
| Zecyte 250mg Tablet 120s | Cipla | ₹28,500.00 | — |
| Samtica 250mg Tablet 120s | Samarth Pharma | ₹29,700.00 | — |
| Abiracure 250mg Tablet 120s | Emcure Pharma | ₹29,900.00 | — |
| Zytiprost 250mg Tablet 120s | Alkem Labs | ₹34,200.00 | — |
| Abitate U Tablet 120s | RPG Life Sciences | ₹39,000.00 | — |
| Arbitus 250mg Tablet 120s | Dr. Reddy | ₹39,500.00 | — |
| Abatitor 250mg Tablet 120s | Torrent Pharma | ₹39,900.00 | — |
| Abstet 250mg Tablet 120s | Biocon Ltd | ₹39,900.00 | — |
| Alkeprost 250mg Tablet 120s | Alkem Labs | ₹45,000.00 | — |
Abiraterone is used in the treatment of metastatic castration-resistant prostate cancer.
Side effects of Abirateron may include Urinary tract infection,Hypokalemia, Hypertension Diarrhoea etc.
Abiraterone is a CYP3A4 substrate and hence should not be administered in patients concurrently on strong CYP3A4 inhibitors or inducers.Likewise it inhibits CYP1A2, CYP2C9 and CYP3A4 and hence should not be given to patients concurrently being treated with substrates of any of these enzymes that have a narrow therapeutic index.
Patients with severe baseline hepatic , impairment , Mineralocorticoid excess , cardiovascular disease, including heart failure and hypertension, uncorrected hypokalaemia , adrenocorticoid insufficiency and Hepatotoxicity that may result from treatment with abiraterone
Abiraterone inhibits 17 α-hydroxylase/C17,20 lyase (CYP17A1), an enzyme which is expressed in testicular, adrenal, and prostatic tumor tissues. CYP17 catalyzes two sequential reactions: (a) the conversion of pregnenolone and progesterone to their 17-α-hydroxy derivatives by its 17 α-hydroxylase activity, and (b) the subsequent formation of dehydroepiandrosterone (DHEA) and androstenedione, respectively, by its C17,20 lyase activity. DHEA and androstenedione are androgens and precursors of testosterone. Inhibition of CYP17 activity by abiraterone thus decreases circulating levels of testosterone.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Abirapro 250 mg Tablet 120s | TAB | ₹28,000.00 |
| Abirapro 500 mg Tablet 60s | TAB | ₹25,000.00 |
| Aceret 10mg Cap 10s | CAP | ₹0.00 |
| Aceret 25mg Cap 10s | CAP | ₹1,055.00 |
| Acinostop 1gm Injection | INJECTION | ₹598.00 |
| Afayro 20 Tablet 28s | TAB | ₹2,700.00 |
| Airlevo Inhaler | INHALER | ₹155.00 |
| Airtec FB 400 Inhaler | INHALER | ₹440.06 |
| Airtec FB 400 Insta Rotacaps 30s | Rotacap | ₹215.00 |
| Airtec FB-100 Inhaler | INHALER | ₹257.00 |
| Airtec FB-100 Instacap Rotacaps | Rotacap | ₹150.00 |
| Airtec FB-200 Inhaler | INHALER | ₹329.00 |
| Airtec FB-200 Rotacaps | Rotacap | ₹197.50 |
| Airtec FF 125 Inhaler | INHALER | ₹350.00 |
| Airtec FF 250 Inhaler | INHALER | ₹509.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist